Clinical Trial Update: Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Phase 3]

View source ↗

Summary

Phase 3 trial comparing adjuvant tamoxifen with anastrozole in postmenopausal women with ductal carcinoma in situ; the study has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19